261 related articles for article (PubMed ID: 15950950)
1. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
[TBL] [Abstract][Full Text] [Related]
2. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
3. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
4. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
5. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
[TBL] [Abstract][Full Text] [Related]
6. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
[TBL] [Abstract][Full Text] [Related]
7. Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs.
Beauséjour CM; Tremblay G; Momparler RL
Biochem Biophys Res Commun; 2000 Nov; 278(3):569-75. PubMed ID: 11095951
[TBL] [Abstract][Full Text] [Related]
8. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
10. 2-Chloro-2'-deoxyadenosine synergistically enhances azidothymidine cytotoxicity in azidothymidine resistant T-lymphoid cells.
Han T; Fernandez M; Chou TC; Agarwal RP
Biochem Biophys Res Commun; 2004 Apr; 316(2):518-22. PubMed ID: 15020247
[TBL] [Abstract][Full Text] [Related]
11. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H
Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583
[TBL] [Abstract][Full Text] [Related]
12. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
[TBL] [Abstract][Full Text] [Related]
13. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
14. Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene.
Owens JK; Shewach DS; Ullman B; Mitchell BS
Cancer Res; 1992 May; 52(9):2389-93. PubMed ID: 1568208
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.
Han T; Fernandez M; Chou TC; Agarwal RP
J Cancer Res Clin Oncol; 2005 Sep; 131(9):609-16. PubMed ID: 16044347
[TBL] [Abstract][Full Text] [Related]
17. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
Leung GP; Man RY; Tse CM
Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
[TBL] [Abstract][Full Text] [Related]
18. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC).
Stegmann AP; Honders MW; Willemze R; Landegent JE
Leukemia; 1995 Jun; 9(6):1032-8. PubMed ID: 7541096
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
[TBL] [Abstract][Full Text] [Related]
20. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]